| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 12/29/2004 | EP1490393A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 12/29/2004 | EP1490392A1 Steroidal quinols as prodrugs of antioxidants |
| 12/29/2004 | EP1490391A1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position |
| 12/29/2004 | EP1490390A2 C-17 spirolactonization and 6,7 oxidation of steroids |
| 12/29/2004 | CN1557829A 5-alpha-androstane-1-alpha,3-beta,17-beta-triol 17-acetate compound and its derivatives and process for preparation thereof |
| 12/29/2004 | CN1557828A Process for preparing 17-beta-subsituted-1-methyl-5-alpha-androst-1-en-3-ones and their derivatives |
| 12/23/2004 | WO2004094451A3 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES |
| 12/23/2004 | US20040259849 17Alpha-hydroxy-14Beta-steroids with hormonal effect |
| 12/22/2004 | EP1487859A2 Process to prepare eplerenone |
| 12/22/2004 | CN1556709A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 12/16/2004 | DE10324496A1 Targetorientierte Chemotherapie von Tumoren der Sexualorgane Target-oriented chemotherapy of tumors of the sexual organs |
| 12/15/2004 | EP1124545B1 Use of 2-methoxyestradiol as anti-fungal agents |
| 12/15/2004 | EP0988311B9 Betulinol derivatives |
| 12/15/2004 | EP0837874B1 Neuroactive steroids of the androstane and pregnane series |
| 12/14/2004 | US6831166 Derivatized oligonucleotides having improved uptake and other properties |
| 12/14/2004 | US6831073 Treating postmenopausal estrogenic deficiencies without appearance of osteoporosis and/or withdrawal bleeding; continuously administering free or esterified estradiol and nomegestrol acetate |
| 12/09/2004 | WO2004106358A1 Target-oriented chemotherapy for treating tumors of the sexual organs |
| 12/09/2004 | US20040249138 for preparing Solanum alkaloid glycosides; Solanum is subjected to methanol extraction, drying the extract and dissolving in a weak volatile acid and centrifuged, the supernatant is precipitated using a volatile base; high purity |
| 12/09/2004 | US20040248870 High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 12/09/2004 | US20040248868 Antiischemic agents; prevent damage to tissues, organs |
| 12/09/2004 | US20040248861 Modified delta5-androstenes having improved bioavailability |
| 12/09/2004 | CA2531319A1 Target-oriented chemotherapy for treating tumors of the sexual organs |
| 12/08/2004 | CN1553917A 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 12/07/2004 | CA2156734C Ozonide reducing agent |
| 12/02/2004 | US20040243316 Crystallographic structure of the androgen receptor ligand binding domain |
| 12/02/2004 | US20040242618 Anticancer agents for prevention of cancer as agonist and antiandrogens |
| 12/02/2004 | US20040241087 Enzyme inhbitors; diagnosis, therapy; antitumor agents, anticancer agents; breast cancer; using a steroid |
| 12/01/2004 | CN1551774A Emergency contraceptive medicinal dose formula and medicinal composition |
| 12/01/2004 | CN1551773A Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 12/01/2004 | CN1551772A Inhibition of the growth factor dependency of tumor cells |
| 11/30/2004 | US6825182 For postmenopausal substitution therapy of gynecological diseases, such as hysteromyomas or dysmenorrhoic symptoms |
| 11/25/2004 | WO2004062606A3 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal |
| 11/25/2004 | US20040235810 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 11/25/2004 | US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner |
| 11/25/2004 | US20040235712 Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same |
| 11/25/2004 | DE10318896A1 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene 8beta-vinyl-11beta- (omega-substituted) alkyl-estra-1,3,5 (10) -trienes |
| 11/24/2004 | EP0688220B1 Use of dhea and derivatives thereof for the manufacture of a medicament for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 11/24/2004 | CN1177046C Enhanced virus-mediated DNA transfer |
| 11/23/2004 | US6821961 Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents |
| 11/18/2004 | WO2004098538A2 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 11/18/2004 | WO2004064722A3 Process for the production of oxandrolone |
| 11/18/2004 | CA2518506A1 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 11/17/2004 | EP1392713A4 Liver x receptor agonists |
| 11/16/2004 | US6818636 B-ring estratrienes |
| 11/11/2004 | WO2004096829A2 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 11/11/2004 | US20040224935 Topical antiandrogenic steroids |
| 11/11/2004 | US20040224933 Reducing compound such as 3,3-ethylenedioxyestra-5(10), 9(11)-dien-17-ol, halogenating, epoxidation, alkylation, deprotecting, aromatization, saponification, neutralization to obtain compound such as 11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)-17-alpha-fluoroestra-1,3,5(10)-trien-3-ol |
| 11/04/2004 | WO2004094451A2 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES |
| 11/04/2004 | WO2004094449A1 Macrolide-conjugates with anti-inflammatory activity |
| 11/04/2004 | WO2004067547A3 Novel steroids and steroid mimetics, method for the production and use thereof |
| 11/04/2004 | US20040220163 Contraceptive method and composition |
| 11/04/2004 | US20040220161 using 6-bromo-3-hydroxyandrostan-17-one |
| 11/04/2004 | US20040220158 5-Androsten-3beta-ol steroid intermediates and processes for their preparation |
| 11/04/2004 | US20040220114 Pharmaceutical compositions and treatment methods |
| 11/04/2004 | CA2522354A1 8beta-vinyl-11beta-(alpha-substituted)alkyl-estra-1,3,5(10)-trienes |
| 11/02/2004 | US6812358 Contacting chemical intermediate with sulfuric acid |
| 10/28/2004 | WO2004085345A3 15α-SUBSTITUTED ESTRADIOL CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 10/28/2004 | US20040214807 Estrogenic compounds as anti-mitotic agents |
| 10/28/2004 | CA2527175A1 Remedies for diseases to be applied to eye |
| 10/27/2004 | EP1470151A1 Process for the preparation of 7-alpha-methylsteroids |
| 10/27/2004 | CN1172949C Testosterone derivative |
| 10/21/2004 | WO2004089971A1 Topical antiandrogenic steroids |
| 10/21/2004 | WO2004089304A2 Antiandrogens with marginal agonist activity and methods of use |
| 10/21/2004 | US20040209853 Orally active 7.alpha.-alkyl androgens |
| 10/19/2004 | US6806263 New 17 alpha -fluoroalkyl steroids of general formula i as antiestrogens |
| 10/14/2004 | US20040204490 Contacting with neurotransmitter recognition site ligand in the presence and absence of a steroid-based molecule; chimeric isoform; use in therapy of neurological disorders including ischemic stroke, epilepsy and schizophrenia |
| 10/12/2004 | US6803198 Carbamate-derivatized nucleosides and oligonucleosides |
| 10/07/2004 | WO2004085458A2 Steroid spirolactonization |
| 10/07/2004 | WO2004085345A2 15α-SUBSTITUTED ESTRADIOL CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 10/07/2004 | US20040198711 steroids formulated in topical dosage form, as creams, gels or suppositories used for therapy or prohylaxis of symptoms associated with menopause |
| 10/07/2004 | CA2519770A1 Steroid spirolactonization |
| 10/06/2004 | CN1534041A Preparation method of tibolong crystal type I |
| 09/30/2004 | DE10259004B4 11β-substituierte Steroide, als Glucocorticoid-Rezeptorantagonisten und deren Verwendung 11β-substituted steroids as glucocorticoid receptor antagonists and the use thereof |
| 09/29/2004 | CN1168448C Medicament for preventing and/or treating a memmary carcinoma, containing a steroidal aromatase inhibitor |
| 09/28/2004 | US6797834 Phosphoric acid isomerization of A 5 (10), 9 (11)—diene steroid to the corresponding 4, 9-diene steroid |
| 09/21/2004 | US6795776 Crystallographic structure of the androgen receptor ligand binding domain |
| 09/16/2004 | WO2004078774A1 Process for the production of tibolone |
| 09/16/2004 | WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen |
| 09/16/2004 | US20040180869 Such as 21-tert.butyl-17-hydroxy-11 beta-(3-methoxyphenyl)-19-nor-17-alpha-pregna-4,9-dien-20-yn-3-one; high binding efficiency, selectivity; reduced side effects |
| 09/16/2004 | US20040180856 Aqueous solution including partially methylated cyclodextrin |
| 09/16/2004 | CA2517934A1 Process for the production of tibolone |
| 09/15/2004 | EP0680327B1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 09/15/2004 | CN1528315A Method for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists |
| 09/14/2004 | US6790843 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/14/2004 | US6790842 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS |
| 09/08/2004 | EP1453851A1 Phosphoric acid isomerization of a 5(10),9(11)-diene steroid to the corresponding 4,9-diene steroid |
| 09/08/2004 | CN1526721A Extraction process of conjugated female hormone |
| 09/07/2004 | US6787659 Process for the production of oxandrolone |
| 09/02/2004 | WO2004074306A1 A continuous process for the production of r-rofleponide |
| 09/02/2004 | US20040171595 new process for the preparation of a key intermediate |
| 08/31/2004 | US6784170 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 08/31/2004 | US6784159 Triterpene saponins from soybeans for treating kidney disease |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/26/2004 | WO2004071427A2 Screening and treatment methods for prevention of preterm delivery |
| 08/26/2004 | US20040166523 Using molecularly imprinted polymers (MIPS) to mimic natural binding events and to screen peptide and steroid libraries; drug screening |
| 08/26/2004 | US20040166090 Antitumor agents; induction apoptosis |
| 08/26/2004 | CA2512989A1 Screening and treatment methods for prevention of preterm delivery |
| 08/25/2004 | EP1448592A1 Steroidal compounds for inhibiting steroid sulphatase |
| 08/25/2004 | EP1448591A1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 08/25/2004 | EP1448207A1 Dosage regimen and pharmaceutical composition for emergency contraception |